Cannopeia

Company Overview

Snapshot

Founded in July 2019 by Jimmy Levy and Bernard Juster, Cannopeia operated with 1–10 employees. The company secured funding in one seed round from Btomorrow Ventures. In November 2020, Cannopeia received seed funding from Btomorrow Ventures.

Business overview

Cannopeia developed proprietary technologies, including a vaporizer and formulation device, to ensure the safe and effective use of cannabis. The company's device allowed medical and non-medical cannabis users to manage consumption by controlling dosage and mixing formulations on demand. Integrating sensors and instruments, the devices gathered data on cannabis treatment effects and efficacy, serving as a personal digital cannabis coach. Cannopeia operated in the Health Tech & Life Sciences sector, specifically within Medical Cannabis, targeting both consumers and patients.

Company Intelligence Q&A

What is Cannopeia's operational status?

Cannopeia is currently non-active, having ceased operations in December 2023.

When was Cannopeia founded and by whom?

Cannopeia was founded in July 2019 by co-founders Jimmy Levy and Bernard Juster.

What was Cannopeia's primary focus?

Cannopeia focused on developing proprietary cannabis vaping technology, including a vaporizer and formulation device designed for safe and effective cannabis use and dosage control.

Which investor participated in Cannopeia's funding round?

In November 2020, Cannopeia received seed funding from Btomorrow Ventures.

What technology did Cannopeia's devices incorporate?

Cannopeia's devices integrated sensors and instruments to gather data on the effects and efficacy of cannabis treatments, aiming to serve as a personal digital cannabis coach for users.